Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 31.38 as of Sunday, July 26, 2026.
Forward PE Ratio (31.38) = Close Price ($337.50) / Consensus Forward EPS ($10.76)
FORWARD PE RATIO
31.38
SECTOR MEDIAN · HEALTHCARE
18.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+70.68%
vs the sector median at left
Intuitive Surgical, Inc.
Market Cap
$119.53B
Forward PE Ratio
31.38
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $119.53B | 31.38 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.16B | 24.83 |
| Stryker Corporation (SYK)vs › | $126.60B | 22.05 |
| Bristol-Myers Squibb Company (BMY)vs › | $126.79B | 9.79 |
| Medtronic plc (MDT)vs › | $106.51B | 15.08 |
| Danaher Corporation (DHR)vs › | $134.62B | 22.57 |
| GSK plc (GSK)vs › | $103.60B | 14.35 |
| CVS Health Corp. (CVS)vs › | $137.47B | 14.48 |
| Pfizer Inc. (PFE)vs › | $139.86B | 8.34 |
| McKesson Corporation (MCK)vs › | $98.45B | 21.56 |
Trailing P/E
38.4
reported TTM EPS
Forward P/E
31.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $10.76 implies +22.4% EPS growth vs the reported trailing $8.79.
At today's $337.50 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $10.76 | $10.40 – $10.95 | 14 | 31.4x |
| 2027-12-31 | $12.03 | $11.82 – $12.67 | 17 | 28.0x |
| 2028-12-31 | $13.54 | $11.96 – $14.95 | 8 | 24.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
